AXELIOS
LIVE

Serial Number

98661935

Owner

Roche Molecular Systems, Inc.

Attorney

Mona Gupta

First Use Date

Jul 21, 2026

Filing Date

Jul 23, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AXELIOS Trademark

Serial Number: 98661935 • Registration: 8451641

AXELIOS is a trademark filed by Roche Molecular Systems, Inc. on July 23, 2024. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

Roche Molecular Systems, Inc. (2 trademarks)

4300 HACIENDA DRIVE
Pleasanton, CA 94588

Entity Type: 03

Trademark Details

Filing Date

July 23, 2024

Registration Date

September 22, 2026

First Use Anywhere

July 21, 2026

First Use in Commerce

July 21, 2026

Published for Opposition

March 4, 2025

Goods & Services

In vitro diagnostic agents, namely, chemical control solutions for calibrating and monitoring the accuracy and function of instruments and test results, chemical additives, enzymes, reagents, organisms and proteins for use in science, research and industry; reagents for cell separation for scientific or research purposes; labeling reagents for scientific or research purposes; reagents for the processing, separation, isolation, enrichment, depletion, detection, screening, cultivation, analysis and counting of material, in particular of chemicals and biological material, all for scientific or research purposes; reagents featuring magnetic beads for scientific or research purposes; antibody reagents for scientific or research purposes; buffer solutions and reagents for use with laboratory apparatus, namely, separation apparatus and analysis apparatus, for scientific or research purposes; reagents for processing biological material, namely, tissue, bone marrow, cells, blood and components thereof for scientific or research purposes; reagents, enzymes, and nucleotides for nucleic acid sequencing for scientific or research purposes; diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes; reagents for scientific or medical research use for analyzing cells, proteins, nucleic acids, sequencing dna, genotyping, gene expression profiling and high through-put screening; reagent kits composed primarily of oligonucleotides, enzymes and buffers for nucleic acid detection in the fields of scientific, pharmaceutical and medical research; nucleic acids, enzymes, buffers and chemical reagents for use in genotyping and gene expression test kits for detecting and analyzing nucleic acids for scientific or research purposes; assays and reagents for scientific or medical research use; diagnostic tests and test kits primarily composed of reagents and nucleotides for determination of genetic information for scientific or research purposes; reagents and chemical test kits for scientific and research use in connection with dna sequencing and genetic analysis

Laboratory apparatus for sample preparation, amplification, mixing, hybridization, incubation, and washing, namely, arrays, beads, bead sets and flow cells; automated laboratory apparatus and systems, namely, sample loaders and bar code readers; quantitative polymerase chain reaction (PCR) instrument for scientific use; scientific equipment, apparatus and instruments, namely, genome sequencers for scientific, pharmaceutical and medical research purpose; downloadable computer software used for genotyping and gene expression microarrays for scientific, pharmaceutical and medical research purposes; downloadable computer software used in analyzing, managing and visualizing dna sequencing data; downloadable computer software used for preparation of nucleic acids libraries; computer hardware and downloadable computer software for collecting, storing, analyzing and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data, all for use in the fields of scientific, diagnostic and clinical research and for clinical diagnostic purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 22, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 22, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Sep 2, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 2, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Sep 2, 2026 SUPC
USE AMENDMENT FILED
Jul 21, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
Jul 21, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 21, 2026 EXRA
SOU EXTENSION 2 GRANTED
Apr 20, 2026 EX2G
SOU EXTENSION 2 FILED
Apr 20, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 20, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 23, 2025 EXRA
SOU EXTENSION 1 GRANTED
Oct 20, 2025 EX1G
SOU EXTENSION 1 FILED
Oct 20, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 20, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 29, 2025 NOAM
PUBLISHED FOR OPPOSITION
Mar 4, 2025 PUBO
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2025 NPUB
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 26, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 10, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 7, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Feb 3, 2025 GNRT
NON-FINAL ACTION WRITTEN
Feb 3, 2025 CNRT
ASSIGNED TO EXAMINER
Jan 30, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2025 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 10, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 10, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 10, 2024 REAP
NEW APPLICATION ENTERED
Jul 23, 2024 NWAP